Medigene AG Expands Protection of its KRAS Library with Filing of New Patent Application Supporting MDG2021 Planegg/Martinsried, September 25, 2024 – Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor...